急性肝衰竭中的出血并发症
研究纳入1998至2016年ALF研究组登记的1770例成人急性肝衰竭患者,分析入院后7天内出血并发症及其与21天死亡率的关系。尽管入院时中位INR为2.7、血小板计数为96×10^9/L,出血并发症仅见于187例(11%),且出血与较低血小板计数相关而非较高INR;任何血制品输注与21天死亡或需肝移植风险增加近2倍相关,但出血并发症仅占死亡直接原因的5%。
要点
- 急性肝衰竭患者临床显著出血不常见,1770例中仅187例(11%)出现出血并发症。
- 出血并发症与较低血小板计数相关,而非与较高INR相关,提示其为严重系统性炎症标志。
- 任何血制品输注与21天死亡或需肝移植风险增加近2倍相关。
核心结论
- 尽管存在出血素质的感知,急性肝衰竭患者临床显著出血不常见,出血并发症是严重系统性炎症而非凝血病的标志,预示预后不良。
研究设计与样本
- 研究为队列分析,纳入1998至2016年ALF研究组登记中的1770例成人急性肝衰竭患者,收集入院后7天内出血并发症和血制品输注情况,评估出血并发症与21天死亡率的关系。
主要发现
- 入院时中位INR为2.7、血小板计数为96×10^9/L,出血并发症见于187例(11%),包括173次自发性出血和22次操作后出血。
- 84%的自发性出血事件来源于上消化道,且很少导致红细胞输注。
- 20例患者发生颅内出血,其中一半为自发性、一半发生于颅内压监测置入后,分别有20%和50%为直接死因。
- 出血患者和接受红细胞输注的患者更因肝外器官系统衰竭而病情急重,而非因肝细胞衰竭;出血并发症与较低血小板计数相关,而非与较高INR相关。
- 任何血制品输注与21天死亡或需肝移植风险增加近2倍相关,但出血并发症仅为5%病例的直接死因。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: In patients with acute liver failure (ALF), elevated prothrombin time and thrombocytopenia can fuel a perception of a bleeding tendency. However, the incidence, site, risk factors, and clinical significance of bleeding complications have not been quantified in a large cohort of patients with ALF. We studied 1,770 adult patients enrolled in the ALF Study Group Registry between 1998 and 2016. Bleeding complications and blood component transfusions were collected for 7 days after admission. The relationship of bleeding complications to 21-day mortality was assessed. Despite a median international normalized ratio of 2.7 and platelet count of 96 × 109 /L on admission, bleeding complications were observed in only 187 patients (11%), including 173 spontaneous and 22 postprocedural bleeding episodes. Eighty-four percent of spontaneous bleeding episodes were from an upper gastrointestinal source and rarely resulted in red blood cell transfusion. Twenty patients experienced an intracranial bleed; half of these occurred spontaneously and half after intracranial pressure monitor placement, and this was the proximate cause of death in 20% and 50%, respectively. Bleeders and patients who received red blood cell transfusions were more acutely ill from extrahepatic organ system failure but not from hepatocellular failure. Consistent with this observation, bleeding complications were associated with lower platelet counts but not higher international normalized ratio. Transfusion of any blood component was associated with nearly 2-fold increased death or need for liver transplantation at day 21, but bleeding complications were the proximate cause of death in only 5% of cases. CONCLUSIONS: Despite a perceived bleeding diathesis, clinically significant bleeding is uncommon in patients with ALF; bleeding complications in patients with ALF are markers of severe systemic inflammation rather than of coagulopathy and so portend a poor prognosis. (Hepatology 2018;67:1931-1942).
引用
- Stravitz RT, Ellerbe C, Durkalski V, et al. Bleeding complications in acute liver failure. Hepatology. 2018. PMID: 29194678. doi:10.1002/hep.29694
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。